Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases

ANZ Journal of Surgery

Volumn 84, Issue 4, 2014, Pages 240-244

  O'Neill, Christine J ^a   Coorough, Nicholas ^b   Lee, James C ^a   Clements, Joshua ^a   Delbridge, Leigh W ^a   Sippel, Rebecca ^b   Sywak, Mark S ^a   Chen, Herb ^b   Sidhu, Stan B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Carcinoma; Local; Neoplasm recurrence; Papillary; Thyroid neoplasm

Indexed keywords

BIOLOGICAL MARKER; THYROGLOBULIN;

BLOOD; CARCINOMA; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; NECK; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; REOPERATION; SURVIVAL; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REOPERATION; SURVIVAL ANALYSIS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84897397421     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12045     Document Type: Article

References (28)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 1994; 97: 418-428.
3. Leboulleux S, Rubino C, Baudin E etal. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J. Clin. Endocrinol. Metab. 2005; 90: 5723-5729.
4. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006; 106: 524-531.
5. Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am. Surg. 2005; 71: 731-734.
6. Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008; 144: 1070-1077; discussion 7-8.
7. Cooper DS, Doherty GM, Haugen BR etal. American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
8. Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J. Surg. 2010; 34: 1239-1246.
9. Kloos RT, Mazzaferri EL. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J. Clin. Endocrinol. Metab. 2005; 90: 5047-5057.
10. Toubeau M, Touzery C, Arveux P etal. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J. Nucl. Med. 2004; 45: 988-994.
11. Lin JD, Huang MJ, Hsu BR etal. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. J. Surg. Oncol. 2002; 80: 45-51.
12. Pelttari H, Valimaki MJ, Loyttyniemi E, Schalin-Jantti C. Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study. Eur. J. Endocrinol. 2010; 163: 757-763.
13. Robbins KT, Shaha AR, Medina JE etal. Consensus statement on the classification and terminology of neck dissection. Arch. Otolaryngol. Head Neck Surg. 2008; 134: 536-538.
14. Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann. Surg. Oncol. 2008; 15: 1177-1182.
15. Bardet S, Malville E, Rame JP etal. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur. J. Endocrinol. 2008; 158: 551-560.
16. Gemsenjager E, Perren A, Seifert B, Schuler G, Schweizer I, Heitz PU. Lymph node surgery in papillary thyroid carcinoma. J. Am. Coll. Surg. 2003; 197: 182-190.
17. Shah MD, Hall FT, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003; 113: 2102-2107.
18. Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 2008; 118: 768-775.
19. Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J. Clin. Endocrinol. Metab. 2010; 95: 2187-2194.
20. Yim JH, Won BK, Kim YK etal. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J. Clin. Endocrinol. Metab. 2011; 96: 2049-2056.
21. Roh JL, Park JY, Kim JM, Song CJ. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J. Surg. Oncol. 2009; 99: 28-31.
22. Binyousef HM, Alzahrani AS, Al-Sobhi SS, Al SH, Chaudhari MA, Raef HM. Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer. World J. Surg. 2004; 28: 1110-1114.
23. Stulak JM, Grant CS, Farley DR etal. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 2006; 141: 489-494; discussion 94-6.
24. Kouvaraki MA, Shapiro SE, Fornage BD etal. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003; 134: 946-954; discussion 54-5.
25. Marshall CL, Lee JE, Xing Y etal. Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. Surgery 2009; 146: 1063-1072.
26. Lang BH, Wong KP, Wan KY, Lo CY. Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann. Surg. Oncol. 2012; 19: 1257-1263.
27. Beal SH, Chen SL, Schneider PD, Martinez SR. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am. Surg. 2010; 76: 28-32.
28. Takada H, Kikumori T, Imai T, Sawaki M, Shibata A, Kiuchi T. Patterns of lymph node metastases in papillary thyroid carcinoma: results from consecutive bilateral cervical lymph node dissection. World J. Surg. 2011; 35: 1560-1566.